COMPANIES COVERED
GlaxoSmithKline plcDownload FREE Report Sample
Download Free sampleXerostomia Therapeutics Market contains market size and forecasts of Xerostomia (Dry Mouth) Therapeutics in global, including the following market information:
Global Xerostomia (Dry Mouth) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Xerostomia (Dry Mouth) Therapeutics Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Xerostomia (Dry Mouth) Therapeutics companies in 2021 (%)
The global Xerostomia (Dry Mouth) Therapeutics market was valued at 703.8 million in 2021 and is projected to reach US$ 851.8 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Salivary Stimulants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Xerostomia (Dry Mouth) Therapeutics include GlaxoSmithKline plc, Church & Dwight, Inc., Colgate-Palmolive Company, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc., Pfizer, Inc. and Parnell Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Xerostomia (Dry Mouth) Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Xerostomia (Dry Mouth) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, by Type, 2021 (%)
Salivary Stimulants
Salivary Substitutes
Dentifrices
Global Xerostomia (Dry Mouth) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, by Application, 2021 (%)
OTC
Prescription
Global Xerostomia (Dry Mouth) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Xerostomia (Dry Mouth) Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Xerostomia (Dry Mouth) Therapeutics revenues share in global market, 2021 (%)
Key companies Xerostomia (Dry Mouth) Therapeutics sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Xerostomia (Dry Mouth) Therapeutics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
